BARISTA Trial Demonstrates Excellent 1-Year Outcomes with Restorer in the Treatment of Iliac Artery Lesions One-year results confirm safety and efficacy across TASC A to D lesions, including complex anatomies Barcelona, February 2026. iVascular announces the year results from the BARISTA Trial, the first... 14 mai Tech & Innovation Autor: Alin Ladaru